This is the first paper to address this gap in knowledge by reporting the results of a cost-effectiveness analysis comparing levocetirizine 5mg with placebo in the treatment of CIU.

In both studies, statistically significant improvements were observed in the pruritus severity score for the levocetirizine 5mg group compared with the placebo group over the 4-week treatment period.